Clinical Trials Logo

Clinical Trial Summary

Fecal Virome Transplantation (FVT) has in small studies shown benefit in the treatment of recurrent C. difficile infection. In the VISION study we will treat patients with recurrent C. difficile infection with FVT capsules and compare the treatment with Fecal Microbiota Transplantation (FMT) capsules. Both will be following af standard treatment of antibiotics (Vancomycin)


Clinical Trial Description

In the VISION study we will treat patients with recurrent C. difficile infection (CDI) with FVT capsules and compare the treatment with Fecal Microbiota Transplantation (FMT) capsules. Patients will be randomised to receive either FMT or FTV capsules. Patients will be followed for one year to investigate the risk of a new recurrence of CDI. Patients and researchers involved in the treatment of the patients will be blinded to the treatment ;


Study Design


Related Conditions & MeSH terms


NCT number NCT06398379
Study type Interventional
Source Copenhagen University Hospital, Hvidovre
Contact Frederik Cold, MD, PhD
Phone 21157167
Email frederik.cold@regionh.dk
Status Not yet recruiting
Phase N/A
Start date May 1, 2024
Completion date December 31, 2026

See also
  Status Clinical Trial Phase
Recruiting NCT06030245 - Clostridioides Difficile Infection: Analyzing CLInic Evolution and Bacterial Clearance
Completed NCT01957761 - Molecular Epidemiology of Clostridium Difficile Infections in Children N/A
Recruiting NCT05714566 - Research on Gut Microbiome and Metabolomics Alterations in C.Difficile Infected IBD Patients
Recruiting NCT06237452 - VE303 for Prevention of Recurrent Clostridioides Difficile Infection Phase 3
Not yet recruiting NCT06107569 - Treatment of CDI and Recurrence With Fecal Microbiota Transplant Using Promicrobioma Phase 3
Not yet recruiting NCT05256693 - Prevention of C.Difficile Infections With Oral Vancomycine in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplant Phase 3
Recruiting NCT06311006 - Safety Registry of a Fecal Microbiota Transplant Cohort
Recruiting NCT05430269 - Faecal Bacteriotherapy for Postantibiotic Diarrhoea in Critically Ill Patients N/A